News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cornerstone BioPharma, Inc. Appoints Alastair McEwan As CFO


10/19/2005 5:12:58 PM

CARY, N.C.--(BUSINESS WIRE)--Sept. 28, 2005--Cornerstone BioPharma, Inc., the Triangle-based specialty pharmaceutical company focused in the CNS (central nervous system), anti-infective, and respiratory markets, today announced Alastair McEwan has joined the company as Chief Financial Officer. McEwan will also be appointed to the company's Board of Directors.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES